Research analysts at StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Get Rating) in a research report issued to clients and investors on Thursday. The firm set a "hold" rating on the stock.
China Pharma Trading Up 4.9 %
NYSE:CPHI opened at $0.38 on Thursday. China Pharma has a 1 year low of $0.33 and a 1 year high of $4.40. The firm has a 50 day moving average of $0.22 and a 200-day moving average of $0.16. The stock has a market capitalization of $1.95 million, a P/E ratio of -0.47 and a beta of 0.59.
Get
China Pharma
alerts:
China Pharma Company Profile
(Get Rating)
China Pharma Holdings, Inc engages in the development, manufacture, and marketing of pharmaceutical products. The firm's product portfolio includes Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases, Comprehensive Healthcare, and Protective Products.
Further Reading
- Get a free copy of the StockNews.com research report on China Pharma (CPHI)
- Dave & Buster's Rebound Could Score for Investors
- Cal-Maine: Is it Time to Chase this Stock Higher?
- The Most Important Warren Buffett Stock for Investors: His Own
- Three Mid Caps Wall Street Sees Doubling Within 12 Months
- It's No Stretch: Lululemon Could Break Out of its Range
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
VIP课程推荐
APP专享直播
热门推荐
收起
24小时滚动播报最新的财经资讯和视频，更多粉丝福利扫描二维码关注（sinafinance）
